Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

Apr 29, 2021

SELL
$72.25 - $168.95 $89,590 - $209,498
-1,240 Closed
0 $0
Q4 2020

Jan 14, 2021

BUY
$125.56 - $178.74 $155,694 - $221,637
1,240 New
1,240 $211,000
Q3 2020

Oct 15, 2020

SELL
$127.12 - $172.34 $160,806 - $218,010
-1,265 Closed
0 $0
Q2 2020

Jul 20, 2020

SELL
$93.0 - $171.7 $128,805 - $237,804
-1,385 Reduced 52.26%
1,265 $203,000
Q1 2020

May 04, 2020

BUY
$82.38 - $131.64 $67,551 - $107,944
820 Added 44.81%
2,650 $259,000
Q4 2019

Feb 13, 2020

BUY
$76.53 - $135.58 $140,049 - $248,111
1,830 New
1,830 $211,000

Others Institutions Holding SRPT

About Sarepta Therapeutics, Inc.


  • Ticker SRPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,567,904
  • Market Cap $10.9B
  • Description
  • Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...
More about SRPT
Track This Portfolio

Track Vigilare Wealth Management Portfolio

Follow Vigilare Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vigilare Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Vigilare Wealth Management with notifications on news.